interleukin-1beta (163-171) has been researched along with gi 129471 in 1 studies
Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (gi 129471) | Trials (gi 129471) | Recent Studies (post-2010) (gi 129471) |
---|---|---|---|---|---|
192 | 3 | 74 | 10 | 0 | 0 |
Protein | Taxonomy | interleukin-1beta (163-171) (IC50) | gi 129471 (IC50) |
---|---|---|---|
Interstitial collagenase | Homo sapiens (human) | 0.02 | |
Low affinity immunoglobulin epsilon Fc receptor | Homo sapiens (human) | 0.04 | |
Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | 5.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colige, A; Foidart, JM; Frankenne, F; Grams, F; Krell, HW; Lambert, C; Maquoi, E; Munaut, C; Noël, A | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and gi 129471
Article | Year |
---|---|
Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
Topics: Collagen Type IV; Enzyme Activation; Fibrosarcoma; Humans; Interleukin-1; Interleukin-1beta; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Peptide Fragments; Phenylalanine; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |